EnCorSQ Mitral Valve Repair System presented at the Mitral Days Heart Surgery Symposium

945

MiCardia has announced that a scientific presentation and a live procedure with the enCorSQ Mitral Valve Repair System were presented at the 2nd Mitral Days Heart Surgery Symposium in Stuttgart, Germany to 200 cardiac surgeons and other professionals.

Martin Andreas, Department of Cardiac Surgery, Medical University of Vienna, Austria, presented a paper on “The Benefit of Adjustable Annuloplasty Rings” and further described the university’s experience with the enCorSQ. The University of Vienna, under the leadership of Gunther Laufer and Alfred Kocher has one of the leading European experiences with the implantation and adjustment of the enCorSQ.

Markus Czesla, Department of Cardiac Surgery, SANA Heart Center in Stuttgart performed a live surgical implant of the enCorSQ utilising a minimally invasive right thoracotomy, which was transmitted to the audience in 3D. In addition, Czesla performed a live adjustment of the enCorSQ. The 65-year-old patient had experienced a recurrence of regurgitation after six months post implant (15–30% of mitral repair patients have recurrent regurgitation within the first year). Once the device was adjusted, the patient’s moderate (MR 2–3) regurgitation was reduced to mild (MR1) in less than one minute. The Stuttgart SANA Heart Center, under the leadership of Nicolas Doll, has one of the most extensive experiences with the implantation and adjustment of the enCorSQ.

According to MiCardia, the enCorSQ device is surgically implanted to treat mitral regurgitation and enables the physician to adjust the device without another surgery to correct any recurrent mitral valve regurgitation that may occur due to the progressive nature of the underlying cardiovascular disease. The adjustment can be achieved, weeks to months post implantation without the need for a repeat high-risk surgical procedure.

“The enCorSQ provides a unique advantage over other annuloplasty rings. With the MiCardia device, recurrent regurgitation can be reduced or eliminated, minimally invasively, without complex redo surgery,” said Kocher.